4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000052
CEO bought 10,400 shares at an average $0.01 ($107)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-10-02 | Purchase : show line 1 in the form | +1,000 | $0.01 | $10 | 25,332,597 | D |
| 2019-10-02 | Purchase : show line 2 in the form | +2,000 | $0.01 | $20 | 25,334,597 | D |
| 2019-10-03 | Purchase : show line 3 in the form | +2,000 | $0.01 | $21 | 25,336,597 | D |
| 2019-10-03 | Purchase : show line 4 in the form | +1,000 | $0.01 | $10 | 25,337,597 | D |
| 2019-10-04 | Purchase : show line 5 in the form | +2,000 | $0.01 | $21 | 25,339,597 | D |
| 2019-10-07 | Purchase : show line 6 in the form | +200 | $0.01 | $2 | 25,339,797 | D |
| 2019-10-15 | Purchase : show line 7 in the form | +2,000 | $0.01 | $21 | 25,341,597 | D |
| 2019-10-15 | Purchase : show line 8 in the form | +200 | $0.01 | $2 | 25,341,797 | D |
| Open-market purchases · 10,400 sh · avg $0.01 · $107 | ||||||
Loading xslF345X03/primary_doc.xml…